Navigation path


European virtual institute for functional genomics of bacterial pathogens - EuroPathoGenomics
EC contribution
: € 6.700.000
: 60 months
Starting date
: 01/07/2005
Funding scheme
: Network of Excellence
: functional genomics, proteomics, infections, bacterial pathogens, vaccination, therapy, education
Contract/Grant agreement number
: LSHB-CT-2005-512061
Project web-site


Bacterial infections remain a major cause of disease and mortality in humans and animals throughout the world. Only the detailed understanding of their pathogenic processes will provide us with innovative tools for their treatment, prevention and possible control and eradication. This concept could contribute to a global policy of control of infections both in Europe and in the developing world. Several infections constitute novel and particularly onerous threats owing to the occurrence of new virulent strains and the development of antibiotic resistances.

The study of infectious disease, which is established in Europe in form of various national research centres and by a considerable number of laboratories, needs a multidisciplinary approach that brings together the different disciplines of molecular biology, immunology, cell biology and structural biology. Although scientific collaborations within Europe have been established to some extent, there is a pressing need for more permanent links and structures between the different disciplines. This task is accomplished by the Network of Excellence "EuroPathoGenomics" (NoE EPG).

The NoE EPG is a consortium of 38 partners from 13 different nations. Innovations in diagnostic techniques and therapy, as well as the development of vaccines against pathogenic microorganisms, are expected to come out of the joint research activities of these top-level European research groups in the field of genomic research.

The three main objectives of the NoE EPG are:

  • stimulation of multidisciplinary collaborative research activities;
  • creation of an European training facility for teaching of scientists and physicians;
  • to foster biotechnological applications and technology transfer to European companies.
[+] Read More